Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinically localised prostate cancer.

Literature DB >> 17124221

Clinically localised prostate cancer.

Timothy J Wilt¹, Ian M Thompson.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2006 PMID： 17124221 PMCID： PMC1661729 DOI： 10.1136/bmj.39022.423588.DE

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

25 in total

Review 1. Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence.

Authors: J M Young; D J Muscatello; J E Ward
Journal: BJU Int Date: 2000-06 Impact factor: 5.588

2. Informing patients about prostate cancer screening: identifying and meeting the challenges while the evidence remains uncertain.

Authors: Melissa R Partin; Timothy J Wilt
Journal: Am J Med Date: 2002-12-01 Impact factor: 4.965

3. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium.

Authors: A W Partin; L A Mangold; D M Lamm; P C Walsh; J I Epstein; J D Pearson
Journal: Urology Date: 2001-12 Impact factor: 2.649

Review 4. Screening for prostate cancer.

Authors: D Ilic; D O'Connor; S Green; T Wilt
Journal: Cochrane Database Syst Rev Date: 2006-07-19

Review 5. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force.

Authors: Russell Harris; Kathleen N Lohr
Journal: Ann Intern Med Date: 2002-12-03 Impact factor: 25.391

Review 6. Prostate cancer epidemiology.

Authors: Henrik Grönberg
Journal: Lancet Date: 2003-03-08 Impact factor: 79.321

7. Quality-of-care indicators for early-stage prostate cancer.

Authors: Benjamin A Spencer; Michael Steinberg; Jennifer Malin; John Adams; Mark S Litwin
Journal: J Clin Oncol Date: 2003-05-15 Impact factor: 44.544

8. The influence of finasteride on the development of prostate cancer.

Authors: Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Gary J Miller; Leslie G Ford; Michael M Lieber; R Duane Cespedes; James N Atkins; Scott M Lippman; Susie M Carlin; Anne Ryan; Connie M Szczepanek; John J Crowley; Charles A Coltman
Journal: N Engl J Med Date: 2003-06-24 Impact factor: 91.245

9. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Authors: Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman
Journal: N Engl J Med Date: 2004-05-27 Impact factor: 91.245

Review 10. Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback.

Authors: David F Ransohoff; Mary McNaughton Collins; Floyd J Fowler
Journal: Am J Med Date: 2002-12-01 Impact factor: 4.965

5 in total

Clinically localised prostate cancer.

Review 1. Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence.

2. Informing patients about prostate cancer screening: identifying and meeting the challenges while the evidence remains uncertain.

3. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium.

Review 4. Screening for prostate cancer.

Review 5. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force.

Review 6. Prostate cancer epidemiology.

7. Quality-of-care indicators for early-stage prostate cancer.

8. The influence of finasteride on the development of prostate cancer.

9. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Review 10. Why is prostate cancer screening so common when the evidence is so uncertain? A system without negative feedback.

Review 1. Benign prostatic hyperplasia. Part 1--diagnosis.

2. Harmonic motion detection in a vibrating scattering medium.

Review 3. Prostate cancer screening and the management of clinically localized disease.

4. Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors.

5. Male incontinence: Pathophysiology and management.